| Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism T Farge, E Saland, F De Toni, N Aroua, M Hosseini, R Perry, C Bosc, ... Cancer discovery 7 (7), 716-735, 2017 | 714 | 2017 |
| Crenolanib is a selective type I pan-FLT3 inhibitor CC Smith, EA Lasater, KC Lin, Q Wang, MQ McCreery, WK Stewart, ... Proceedings of the National Academy of Sciences 111 (14), 5319-5324, 2014 | 244 | 2014 |
| c-Myb, Menin, GATA-3, and MLL form a dynamic transcription complex that plays a pivotal role in human T helper type 2 cell development Y Nakata, AC Brignier, S Jin, Y Shen, SI Rudnick, M Sugita, AM Gewirtz Blood, The Journal of the American Society of Hematology 116 (8), 1280-1290, 2010 | 73 | 2010 |
| Hematopoietic cytokines mediate resistance to targeted therapy in FLT3-ITD acute myeloid leukemia PJ Sung, M Sugita, H Koblish, AE Perl, M Carroll Blood advances 3 (7), 1061-1072, 2019 | 55 | 2019 |
| c-Myb and GATA-3 cooperatively regulate IL-13 expression via conserved GATA-3 response element and recruit mixed lineage leukemia (MLL) for histone modification of the IL-13 locus T Kozuka, M Sugita, S Shetzline, AM Gewirtz, Y Nakata The Journal of Immunology 187 (11), 5974-5982, 2011 | 37 | 2011 |
| Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia M Sugita, R Galetto, H Zong, N Ewing-Crystal, V Trujillo-Alonso, ... Nature communications 13 (1), 2227, 2022 | 36 | 2022 |
| Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells T Cai, A Gouble, KL Black, A Skwarska, AS Naqvi, D Taylor, M Zhao, ... Nature communications 13 (1), 2228, 2022 | 21 | 2022 |
| Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia M Sugita, DC Wilkes, R Bareja, KW Eng, S Nataraj, RA Jimenez-Flores, ... NPJ precision oncology 5 (1), 44, 2021 | 21 | 2021 |
| Crenolanib (CP-868,596) is a potent and selective type I FLT3 inhibitor that retains activity against AC220 resistance-causing FLT3 kinase domain mutants CC Smith, E Lasater, M Mccreery, K Lin, W Stewart, LE Damon, AE Perl, ... Blood 120 (21), 141, 2012 | 21 | 2012 |
| BCL6 maintains survival and self-renewal of primary human acute myeloid leukemia cells KC Kawabata, H Zong, C Meydan, S Wyman, BJ Wouters, M Sugita, ... Blood, The Journal of the American Society of Hematology 137 (6), 812-825, 2021 | 20 | 2021 |
| CD123 as a therapeutic target against malignant stem cells M Sugita, ML Guzman Hematology/Oncology Clinics 34 (3), 553-564, 2020 | 19 | 2020 |
| Allogeneic Tcrα/β deficient CAR T-cells targeting CD123 prolong overall survival of AML patient-derived xenografts ML Guzman, M Sugita, H Zong, N Ewing-Crystal, V Trujillo-Alonso, ... Blood 128 (22), 765, 2016 | 18 | 2016 |
| Eltrombopag inhibition of acute myeloid leukemia cell survival does not depend on c-Mpl expression M Sugita, A Kalota, AM Gewirtz, M Carroll Leukemia 27 (5), 1207-1210, 2013 | 18 | 2013 |
| Selection and characterization of antibody clones are critical for accurate flow cytometry-based monitoring of CD123 in acute myeloid leukemia NM Cruz, M Sugita, N Ewing-Crystal, L Lam, R Galetto, A Gouble, J Smith, ... Leukemia & lymphoma 59 (4), 978-982, 2018 | 17 | 2018 |
| Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi‐centre setting D Hanekamp, AN Snel, A Kelder, WJ Scholten, N Khan, M Metzner, ... British journal of haematology 190 (6), 891-900, 2020 | 15 | 2020 |
| Colocolic intussusception associated with pneumatosis cystoides intestinalis after cord blood stem cell transplantation M Sugita, T Mori, H Shimada, N Shimasaki, Y Morikawa, T Takahashi Journal of pediatric gastroenterology and nutrition 38 (5), 549-551, 2004 | 13 | 2004 |
| Epstein-Barr Virus–Associated Posttransplant Lymphoproliferative Disorder After a Cord Blood Stem Cell Transplantation Presenting With Pulmonary Nodules N Shimasaki, T Mori, H Shimada, M Sugita, M Higuchi, M Mukai, T Morio, ... Journal of Pediatric Hematology/Oncology 26 (2), 124-127, 2004 | 12 | 2004 |
| Chemical probes and methods for single-cell detection and quantification of epichaperomes in hematologic malignancies S Merugu, S Sharma, J Kaner, C Digwal, M Sugita, S Joshi, T Taldone, ... Methods in enzymology 639, 289-311, 2020 | 9 | 2020 |
| CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insights N Pemmaraju, NR Wilson, J Senapati, MP Economides, ML Guzman, ... Leukemia Research 121, 106928, 2022 | 8 | 2022 |
| Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia M Sugita, T Yamazaki, M Alhomoud, J Martinet, JB Latouche, E Golden, ... Cell Death & Disease 14 (5), 305, 2023 | 7 | 2023 |
